Is ARAY Worth Buying in 2026?

Accuray Incorporated

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-05-24

Here’s whether Accuray Incorporated (ARAY) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-9.22% over 10 days); weak 1-year return of -80.6%; 3-month momentum negative (-48.2%); rising volume on a downtrend (distribution, 2.20x avg). Currently 85.4% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

ARAY is trading below its 200-day MA ($0.96) — a key warning sign the longer-term trend is under pressure. An RSI of 34.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -80.6% compares to +27.9% for SPY (trailed the market by 108.5%). The current 85.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $1,942 today
vs. S&P 500 (SPY) — same period trailed market by 108.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($0.96)
Above 50-day MA ($0.39)
RSI(14) neutral zone (30–70) — currently 34.7
Positive return (-80.6%)
!Within 10% of period high (−85.4%)
Period Range $0.31
$0.25 $2.10
RSI (14) 34.7
0 · OversoldOverbought · 100

Key Metrics

Price$0.31
Period Return-80.6%
Period High$2.10
Period Low$0.25
Drawdown−85.4%
MA-50$0.39
MA-200$0.96
RSI (14)34.7
Avg Volume (30d)3.8M
vs. SPYtrailed by 108.5%
Return Rank#1175 of 1236

Trade ARAY

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers